Skip to main content

Advertisement

SpringerLink
Log in

Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab

  • Letter to the Editor - Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Edwards JC, Szczepanski L, Szechinski J et al (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350:2572–2581

    Article  CAS  PubMed  Google Scholar 

  2. McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205–2219

    Article  CAS  PubMed  Google Scholar 

  3. Nakken B, Munthe LA, Konttinen YT et al (2011) B-cells and their targeting in rheumatoid arthritis-current concepts and future perspectives. Autoimmun Rev 11:28–34

    Article  CAS  PubMed  Google Scholar 

  4. Mèlet J, Mulleman D, Goupille D et al (2013) Rituximab-induced T cell depletion in patients with rheumatoid arthritis. Association with clinical response. Arthritis Rheum 65:2783–2790

    Article  PubMed  Google Scholar 

  5. Crowe SM, Carlin JB, Stewart KI et al (1991) Predictive value of CD4 lymphocyte numbers for the development of opportunistic infection and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 4:770–776

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy

    Silvia Piantoni & Angela Tincani

  2. Rheumatology Chair, University of Pavia, Pavia, Italy

    Silvia Piantoni

  3. Rheumatology and Clinical Immunology Unit, Spedali Civili of Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy

    Mirko Scarsi & Paolo Airò

Authors
  1. Silvia Piantoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mirko Scarsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angela Tincani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paolo Airò
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Silvia Piantoni.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Piantoni, S., Scarsi, M., Tincani, A. et al. Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab. Rheumatol Int 35, 1571–1573 (2015). https://doi.org/10.1007/s00296-015-3295-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-015-3295-0

Keywords

Search

Navigation